摘要
Background: Coronavirus disease 2019 (COVID-19) has become a global pandemic which may compromise the management of vascular emergencies. An uncompromised treatment for ruptured abdominal aortic aneurysm (rAAA) during such a health crisis represents a challenge. This study aimed to demonstrate the treatment outcomes of rAAA and the perioperative prevention of cross-infection under the COVID-19 pandemic.
-
单位1; 广州医学院; 哈尔滨医科大学; 南方医科大学; 佛山市第一人民医院; 广东省人民医院; 华中科技大学; 广东医学院; 中山大学; 浙江大学; 中国医科大学